{"nct_id":"NCT07125872","title":"Open Label, Phase 2 Study of CD19t-haNK and N-803 in Combination With Rituximab in Participants With Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma.","status":"NOT_YET_RECRUITING","status_verified_date":"2025-05","start_date":"2025-08-19","start_date_type":"ESTIMATED","primary_completion_date":"2027-05-25","primary_completion_date_type":"ESTIMATED","completion_date":"2028-05-25","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["IBRX"]}